We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Berkeley Scot | LSE:BGP | London | Ordinary Share | GB00B03W5P29 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 22.59 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/1/2002 20:01 | But does this also mean that the directors and their options will be well looked after. The issue will have to be ratified at an EGM. It will be interesting to see the price tomorrow.. Meanwhile buy some PRM in compensation. | saturn5 | |
31/1/2002 19:45 | "Yes" to put it bluntly, but the board did warn shareholders in their last announcement regarding a potential bid. BTG | bruce the goldfish | |
31/1/2002 18:27 | From the RNS On the basis of this indicative offer, the total consideration (which may or may not be offered) would not exceed the current level of debt of the Company. Does this mean the shareholders get nothing ? | saturn5 | |
31/1/2002 18:03 | 2.5M blue buys looks as if someone is in the know. I reckon the share price is going to rise prior to the dilution effect. What I cannot decide is whether to buy or not. I have the cash but I am in deep already. What do you seasoned posters who have been in the discussion for a good while think. Are we BUYING or not or are we waiting until Q makes the move. If this comes off then we make more more cash. I could do a T10 as soon as the news breaks. Not much risk there. Come on spill the beans. | saturn5 | |
31/1/2002 17:03 | RNS just released - Deutsche Asset Mngmnt sells 250k @6p Still hold 3.4% of the co. but why sell? | wetdream | |
31/1/2002 16:55 | Pretty amazing trading - 2.4m bought vs 0.004m sold...no move in price... Announcement tomorrow - or in 5 minutes?!! | wetdream | |
31/1/2002 16:50 | If someone is preparred to spend £70,000 I would say something good is going to happen. Still no announcement ??????? | dryboy | |
31/1/2002 16:36 | Those 1 million buys are more than just a gamble IMO | conc2 | |
31/1/2002 16:15 | S, perhaps that was his 196k buy that just went through?! | wetdream | |
31/1/2002 16:15 | no people that was mine. It just a gamble. | maniben | |
31/1/2002 16:06 | Ask Mali-7 | sunya | |
31/1/2002 11:56 | Not another bloody extension. I wish it would just do or die. Like many, I'm holding as it's not worth selling - and you ain lost 'till you've sold 'em. | evansmi | |
31/1/2002 11:07 | Heavens knows who they leave this deal so late. Right up to the wire or perhaps we thought there was a deadline. | saturn5 | |
31/1/2002 10:46 | Cheer up! Extract from today's Ft.com article: '...Analysts said the new Quintiles deal, entitling it to the marketing rights for Bioglan's core dermatology products in the US - is estimated to be worth tens of millions of pounds. RBS is expected today to extend Bioglan's debt facilities for a further month..' | wetdream | |
31/1/2002 08:30 | Can you hear the sound of hooves in the distance? Will the cavalry arrive in time to save the day? Back in at 6.5p | hogarth | |
31/1/2002 08:18 | Could be the reason? LONDON (AFX) - Bioglan Pharma PLC is in late-stage rescue talks with Quintiles Transnational, the US contract research group, according to the Financial Times. The newspaper did not name its source, but said the deal, which could give Quintiles up to 30 pct of Bioglan through a share issue, would force Terry Sadler, Bioglan's founder and chief executive, finally to accept a dilution of his holding. Sadler, whose one-third stake was worth 577 mln stg at the shares' high point of 902-1/2 pence early last year, was worth less than 2 mln stg at Wednesday's closing price of 5-3/4 pence. Bioglan's tailspin began last October, when Sadler confirmed he had abandoned the 765 mln usd acquisition of Bristol Myers Squibb's skincare operations. Choosing debt rather than equity as the basis for that deal had triggered the company's problems, analysts said. Bioglan still owes 105 mln stg to a consortium of banks led by Royal Bank of Scotland PLC. | hogarth | |
31/1/2002 08:06 | up 8.3% this am. Anyone possess news ? | sunya | |
30/1/2002 09:14 | wheres mali7 gone anybody checked the A&E lately | lovegod | |
30/1/2002 09:04 | Not surprised where hardly any buyers with a 26% spread. MM`s playing games again! | sholcroft | |
29/1/2002 23:37 | Hmmmm......hardly worth selling these now. Stuck with it for a few months now so I`m just gonna see what happens. | sholcroft | |
29/1/2002 23:14 | Of course the MMs could have a big buy order waiting??? | saturn5 | |
29/1/2002 17:20 | Let this die with some dignity Require my services yet ?? | the_undertaker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions